FOLFIRI + Cetuximab

From OncoWiki
Jump to: navigation, search

Indication

Chemotherapy for stage IV (metastatic) cancer

  • Leucovorin 400 mg/m2 iv over 2 hrs before 5-FU d1 q2w
  • 5-FU 400 mg/m2 iv bolus d1, and then 2400 mg/m2 iv over 46 hrs q2w
  • Irinotecan (Camptosar, CPT-11) 180 mg/m2 iv d1 q2w
  • Cetuximab (Erbitux) 400 mg/m2 iv loading d1, and then 250 mg/m2 iv qw

References

Van Cutsem E et al. Randomized phase III study of irinotecan and 5-FU/FA with or without cetuximab in the first-line treatment of patients with metastatic colorectal cancer (mCRC): The CRYSTAL trial. 2007 ASCO annual meeting. Abstract 4000